GO
| HSI1 | 26,361.07 | 0.00 | -- |
| HSCEI1 | 8,899.06 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2026-04-20 09:30:23 MABWELL-B (02493.HK), a Chinese pharmaceutical company, started its IPO today (20th). The company proposes to offer 47.1302 million shares globally, with 10% allocated to the Hong Kong public offering and 90% to the international offering. The offer price ranges from HKD27.64 to HKD30.71 per share. The entry fee for a board lot of 200 shares is HKD6,203.95. The IPO period will close at noon on Thursday (23rd), and the shares are expected to be listed next Tuesday (28th). MABWELL-B has introduced six cornerstone investors for its IPO, including Junshi Hong Kong under JUNSHI BIO (01877.HK), Guohui HK under Shandong Development Investment Holding Group, and WuXi Biologics Venture under WUXI BIO (02269.HK), which have collectively subscribed for USD53 million worth of shares. ~ AAStocks Financial News Web Site: www.aastocks.com | |